Member news

Formycon Reports on Virtual Annual General Meeting 2021

More at formycon.com…

Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm

More at rentschler-biopharma.com…

Formycon Publishes Half-Year Results for 2021

More at formycon.com…

Cellbox Solutions Establishes Subsidiary in the USA

More at b3cnewswire.com…

Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer, strengthening scientific focus

More at rentschler-biopharma.com…

PAION AG ANNOUNCES INITIATION OF PIVOTAL STUDY OF REMIMAZOLAM (BYFAVO(R)) IN PEDIATRIC PROCEDURAL SEDATION

More at paion.com…

Medigene's PD1-41BB switch receptor improves TCR-T cell functionality against solid tumors

More at medigene.com…

BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives

More at brain-biotech.com…

Formycon's COVID-19 drug FYB207 Wins Prestigious Pharma Trend Image & Innovation Award 2021

More at formycon.com…

CureVac Streamlines European Network for mRNA Product Manufacturing

More at curevac.com…

Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with ATAC Candidate HDP-101 in the US

More at heidelberg-pharma.com…

Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential

More at brain-biotech.com…

PAION signs exclusive UK supply and distribution agreement with CLINIGEN

More at paion.com…